IL6 and neoplasm: Galiellalactone also suppresses the production of immunosuppressive cytokines IL-10, IL-1β, IL-6 in monocytes, while reducing factors that drive MDSC recruitment and expansion in tumor cells such as IL-8 and GM-CSF.